Pyridine nucleotides
Sigma Aldrich Fine Chemicals Biosciences Nicotinamide European Phar
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. for further information and support please go to the website of the issuing Pharmacopoeia.Nicotinamide belongs to the group of water-soluble B vitamins. It is generally formed from nicotinic acid (vitamin B3). It is available in food products and is utilized for the treatment of pellagra psoriasis nbspschizophrenia andnbsptype I diabetes. It is also known for its anti-inflammatory activity.
Selleck Chemical LLC b-Nicotinamide Mononucleotide S5259-500mg
Nicotinamide mononucleotide ( -NM NMN) one of the key precursors of NAD and products of the NAMPT reaction is converted to NAD by nicotinamide mononucleotide adenylyltransferase
Selleck Chemical LLC b-Nicotinamide Mononucleotide S5259-100mg
Nicotinamide mononucleotide ( -NM NMN) one of the key precursors of NAD and products of the NAMPT reaction is converted to NAD by nicotinamide mononucleotide adenylyltransferase
Selleck Chemical LLC Nicotinamide Riboside Chloride S2935-10mM/1mL
Nicotinamide Riboside Chloride is the chloride salt form of nicotinamide riboside(NR) NR is a new form pyridine-nucleoside of vitamin B3 that functions as a precursor to nicotinamide adenine dinucleotide(NAD) or NAD Nicotinamide riboside chloride is a crystal form of Nicotinamide riboside (NR) chloride Nicotinamide riboside chloride increases NAD[ ] levels and activates SIRT1 and SIRT3 culminating in enhanced oxidative metabolism and protection against high fat diet-induced metabolic abnormalities Nicotinamide riboside chloride is used in dietary supplements
Selleck Chemical LLC Nicotinamide S1899-5g
Nicotinamide a water-soluble vitamin is an active component of coenzymes NAD and NADP and also act as an inhibitor of sirtuins
Chem-Impex International, Inc. b-Nicotinamide adenine dinucleotide | 53-84-9 | MFCD00036253 | 1G
b-Nicotinamide adenine dinucleotide, 53-84-9, MFCD00036253, 1G
Sigma Aldrich Fine Chemicals Biosciences beta-Nicotinamide adenine dinucleotide hydrate purified by column chromatography, >=99% | 53-84-9 | MFCD00036253 | 1G
beta-Nicotinamide adenine dinucleotide hydrate purified by column chromatography, >=99% | Purity: >=99% | 53-84-9 | MFCD00036253 | 1G
Sigma Aldrich Fine Chemicals Biosciences beta-Nicotinamide adenine dinucleotide hydrate Grade AA-1 | 53-84-9 | MFCD00036253 | 12X600MG
beta-Nicotinamide adenine dinucleotide hydrate Grade AA-1 | 53-84-9 | MFCD00036253 | 12X600MG
Sigma Aldrich Fine Chemicals Biosciences beta-Nicotinamide adenine dinucleotide hydrate >=98%, BioUltra, from yeast | 53-84-9 | MFCD00036253 | 1G
beta-Nicotinamide adenine dinucleotide hydrate >=98%, BioUltra, from yeast | Purity: >=98% | 53-84-9 | MFCD00036253 | 1G
Sigma Aldrich Fine Chemicals Biosciences Beta-Nicotinamide adenine dinucleotide | 53-84-9 | MFCD00036253 | 15 vials 20 mg each
Beta-Nicotinamide adenine dinucleotide | Mol Wt: 663.43 | 53-84-9 | MFCD00036253 | 15 vials 20 mg each
Sigma Aldrich Fine Chemicals Biosciences beta-Nicotinamide adenine dinucleotide hydrate >=98%, BioUltra, from yeast | 53-84-9 | MFCD00036253 | 250MG
beta-Nicotinamide adenine dinucleotide hydrate >=98%, BioUltra, from yeast | Purity: >=98% | 53-84-9 | MFCD00036253 | 250MG
Indofine Chemical UREA, MOLECULAR BIOLOGY GRADE, Products for Life Science, 57-13-6, 99.5+%, 1 kg
UREA, MOLECULAR BIOLOGY GRADE, Products for Life Science, 57-13-6, 99.5+%, 1 kg
Crescent Chemical Co Inc NICOTINAMIDE ADENINE DINUCLEOT
Nicotinamide adenine dinucleotide analytical grade Size - 1G Storage Conditions - +2 °C TO +8 °C Catalog Number - 30311.02 CAS 53-84-9
Apexbio Technology LLC NICOTINAMIDE 5G
Nicotinamide (CAS 98-92-0) is a small-molecule inhibitor of poly(ADP-ribose) polymerase-1 (PARP-1) an enzyme critical in DNA repair pathways Under pathological conditions such as ischemia or trauma PARP-1 hyperactivation depletes cellular NAD triggering neuronal cell death In vitro studies indicate that transporter-mediated uptake of nicotinamide confers protection against PARP-1-induced astrocyte injury In vivo studies in diabetic rat models demonstrate that nicotinamide administration normalizes hepatic antioxidant enzymes reducing oxidative stress Clinical trials have shown dose-dependent upregulation of frataxin expression following sustained nicotinamide treatment suggesting therapeutic potential in disorders like Friedreich s ataxia